| Product Code: ETC12465519 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Immunotherapy Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Immunotherapy Drugs Market - Industry Life Cycle |
3.4 Thailand Immunotherapy Drugs Market - Porter's Five Forces |
3.5 Thailand Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Thailand Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Thailand Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Thailand Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Thailand Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Thailand Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in Thailand |
4.2.2 Growing awareness about the benefits of immunotherapy treatment |
4.2.3 Favorable government initiatives and policies supporting the adoption of immunotherapy drugs |
4.3 Market Restraints |
4.3.1 High cost associated with immunotherapy drugs |
4.3.2 Limited availability and accessibility of advanced immunotherapy treatments in Thailand |
5 Thailand Immunotherapy Drugs Market Trends |
6 Thailand Immunotherapy Drugs Market, By Types |
6.1 Thailand Immunotherapy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Thailand Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F |
6.1.4 Thailand Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 Thailand Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F |
6.1.6 Thailand Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.7 Thailand Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F |
6.2 Thailand Immunotherapy Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Thailand Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Thailand Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2.5 Thailand Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.2.6 Thailand Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.3 Thailand Immunotherapy Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Thailand Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.3 Thailand Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Thailand Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Thailand Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Thailand Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Thailand Immunotherapy Drugs Market, By Mechanism of Action |
6.4.1 Overview and Analysis |
6.4.2 Thailand Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F |
6.4.3 Thailand Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F |
6.4.4 Thailand Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F |
6.4.5 Thailand Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F |
6.4.6 Thailand Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.5 Thailand Immunotherapy Drugs Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Thailand Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Thailand Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Thailand Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Thailand Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Thailand Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Thailand Immunotherapy Drugs Market Import-Export Trade Statistics |
7.1 Thailand Immunotherapy Drugs Market Export to Major Countries |
7.2 Thailand Immunotherapy Drugs Market Imports from Major Countries |
8 Thailand Immunotherapy Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for immunotherapy drugs conducted in Thailand |
8.2 Percentage increase in the adoption of immunotherapy drugs among healthcare facilities in Thailand |
8.3 Rate of investment in research and development of new immunotherapy drugs in Thailand |
9 Thailand Immunotherapy Drugs Market - Opportunity Assessment |
9.1 Thailand Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Thailand Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Thailand Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Thailand Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.5 Thailand Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Thailand Immunotherapy Drugs Market - Competitive Landscape |
10.1 Thailand Immunotherapy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here